Methamphetamine-Induced Thyroid Dysfunction

Diagnostic Considerations

TSH levels are frequently suppressed during acute phases of stimulant use, as TSH secretion is highly sensitive to factors other than primary thyroid disorders, according to the American College of Physicians, with a strength of evidence level of moderate 1, 2
Do not rely on a single TSH value to establish thyroid dysfunction in methamphetamine users, as TSH levels can vary by up to 50% of mean values on a day-to-day basis, with up to 40% variation in serial measurements performed at the same time of day, as recommended by the American College of Physicians 1, 2
Serial TSH measurements are essential to establish that thyroid disorder is real and persistent rather than transient drug effect, as suggested by the American College of Physicians, with a strength of evidence level of high 1, 2
Serum TSH is frequently suppressed during phases of acute illness or drug use, making timing of assessment critical, according to the American College of Physicians, with a strength of evidence level of moderate 1, 2

Recheck TSH and free T4 after 3-6 weeks of abstinence from methamphetamine to distinguish between drug-induced suppression and true thyroid disease, as 30-60% of abnormal TSH levels normalize on repeat testing, as recommended by the Endocrine Society, with a strength of evidence level of low 3
Measure both TSH and free T4 to distinguish between drug-induced central suppression (low TSH with normal or elevated free T4) and primary thyroid disease, as suggested by the Endocrine Society, with a strength of evidence level of moderate 3
Assess for symptoms of hyperthyroidism (tachycardia, tremor, heat intolerance, weight loss) versus symptoms attributable to methamphetamine use itself, as recommended by the Endocrine Society, with a strength of evidence level of low 3

Do not initiate thyroid hormone treatment based on abnormal TSH alone in active methamphetamine users, as the suppression is typically drug-induced rather than indicating true hypothyroidism, as recommended by the American College of Physicians, with a strength of evidence level of high 1, 2
Never start thyroid hormone replacement before ruling out adrenal insufficiency in patients with suspected central hypothyroidism from methamphetamine use, as this can precipitate adrenal crisis, as suggested by the Endocrine Society, with a strength of evidence level of high 3
Reassess thyroid function 3-6 weeks after cessation of methamphetamine use to determine if abnormalities persist, as recommended by the Endocrine Society, with a strength of evidence level of low 3